Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection

Frost JN. et al, (2020), Med

Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation

Rahikainen R. et al, (2020), Angewandte Chemie

The Structure of the Cysteine-Rich Domain of Plasmodium falciparum P113 Identifies the Location of the RH5 Binding Site

Campeotto I. et al, (2020), mBio, 11

Low immunogenicity of malaria pre-erythrocytic stages can be overcome by vaccination

Müller K. et al, (2020)

Overcoming Symmetry Mismatch in Vaccine Nanoassembly via Spontaneous Amidation

Howarth M. et al, (2020), Angewandte Chemie International Edition

Combinatorial Tim‐3 and PD‐1 activity sustains antigen‐specific Th1 cell numbers during blood‐stage malaria

Dookie RS. et al, (2020), Parasite Immunology, 42

A Humanized Mouse Model for Plasmodium vivax to Test Interventions that Block Liver Stage to Blood Stage Transition and Blood Stage Infection.

Schäfer C. et al, (2020), iScience, 23

Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations.

Azasi Y. et al, (2020), Scientific reports, 10

Structure of the cysteine-rich domain of Plasmodium falciparum P113 identifies the location of the RH5 binding site

Campeotto I. et al, (2020)

The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target

Ragotte RJ. et al, (2020), Trends in Parasitology, 36, 545 - 559

Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia

Arezes J. et al, (2020), Blood

Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools.

De Groot AS. et al, (2020), Frontiers in immunology, 11

Design of a basigin‐mimicking inhibitor targeting the malaria invasion protein RH5

Warszawski S. et al, (2020), Proteins: Structure, Function, and Bioinformatics, 88, 187 - 195

Functional Characterization and Comparison of Plasmodium falciparum Proteins as Targets of Transmission-blocking Antibodies.

Nikolaeva D. et al, (2020), Molecular & cellular proteomics : MCP, 19, 155 - 166

Harmonization study between three laboratories for expression of malaria vaccine clinical trial IgG antibody ELISA data in µg/mL

Labbé GM. et al, (2019), Malaria Journal, 18

Antibodies Against the Erythroferrone N-Terminal Domain Prevent Hepcidin Suppression and Ameliorate Murine Thalassemia

Arezes J. et al, (2019), BLOOD, 134

Production and characterisation of the first human monoclonal antibodies against Plasmodium falciparum transmission blocking antigen Pfs25

Zaric M. et al, (2019), EUROPEAN JOURNAL OF IMMUNOLOGY, 49, 1683 - 1684

Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody

Rawlinson TA. et al, (2019), Nature Microbiology, 4, 1497 - 1507

Adeno-associated viral vectored delivery of a monoclonal antibody gene against blood-stage malaria

Bardelli M. et al, (2019), HUMAN GENE THERAPY, 30, A11 - A11

New strategy of cancer vaccination by a hybrid bacteriophage vector and a malaria vaccine

Waramit S. et al, (2019), HUMAN GENE THERAPY, 30, A13 - A13

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?